Stryker Hip Lawsuit Attorneys at Bernstein Liebhard LLP Note Upcoming Conferences in New Jersey LFIT V40 Femoral Head Litigation

NEW YORK, March 21, 2018 /PRNewswire-USNewswire/ -- The New Jersey Superior Court overseeing nearly 150 hip replacement lawsuits involving Stryker's allegedly defective LFIT Anatomic CoCr V40 Femoral Head components is scheduled to convene two important conferences in the coming weeks.

According to a Case Management Order issued in Bergen County Superior Court on March 16^th, the Court will conduct a teleconference on March 28^th at 11:00 a.m. to discuss the selection of cases for the multi-county litigation's future bellwether trials. The Order further directs the parties to meet and confer on bellwether case selection prior to the conference.

The March 16th Order also indicates that the Court will convene its next regular Case Management Conference on April 25^th, starting with a meeting of the executive committee at 10:00 a.m.  The conference record will begin at 11:00 a.m. (In Re: Stryker LFIT CoCr V40 Femoral Heads Hip Implant Litigation, Case No. 624)

"Our Firm is representing a number of Stryker hip lawsuit plaintiffs in claims involving LFIT V40 Femoral Heads and we will be monitoring these proceedings closely. The conference regarding bellwether case selection is of particular interest, as verdicts in these trials are intended to provide insight into how other juries might rule in similar hip replacement lawsuits," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to individuals who may have been harmed by Stryker's LFIT Anatomic CoCr V40 Femoral Heads.

Stryker LFIT V40 Femoral Heads

Around 150 Stryker hip replacement lawsuits have been filed in Bergen County Superior Court on behalf of plaintiffs who experienced painful and debilitating complications allegedly related to the failure of an LFIT V40 femoral head. An additional 223 federally-filed cases involving these components have been centralized in the U.S. District Court, District of Massachusetts. (In RE: Stryker Orthopaedics LFIT V40 Femoral Head Product Liability Litigation, MDL NO. 2768)

Stryker's LFIT V40 femoral heads are designed to be used in conjunction with many of the company's modular hip stems, including:

• Accolade^® TMZF Femoral Stem
• Accolade II^® Femoral Stem
• Restorationtm Femoral Hip Stem
• Rejuvenate^® Monolithic Stem
• ABG II Monolithic Femoral Stem
• Hipstar^® Femoral Stem
• Citation TMZF HA Stem
• Meridian^® PA Femoral Stem
• Exeter^® V40tm Femoral Stem
• Reliance^® PF Femoral Stem

In August 2016, Stryker announced a worldwide recall for certain LFIT Anatomic CoCr V40 Femoral Heads manufactured prior to 2011. The action was taken after the company received an unusually high number of reports involving taper lock failure. Taper lock failure may result in loosening of the artificial joint and other debilitating complications, including:

• Loss of mobility
• Pain
• Inflammation
• Adverse local tissue reaction
• Dislocation
• Joint instability
• Bone fractures around the components
• Leg length discrepancy
• Need for revision surgery

The U.S. Food & Drug Administration (FDA) placed the Stryker hip recall in its Class II category, which indicates that the affected components could cause temporary or medically-reversible health consequences.

Individuals who suffered premature device failure or other complications due to allegedly defective LFIT V40 femoral head components may be entitled to compensation for medical bills, lost wages, pain and suffering, and more.  To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2018 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/
https://plus.google.com/115936073311125306742?rel=author

SOURCE Bernstein Liebhard LLP